The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects

S.H. Donze, C.R. Meijer, S.G. Kant, G.R.J. Zandwijken, A.H. van der Hout, R.M.L. van Spaendonk, A.M.W. van den Ouweland, J.M. Wit, M. Losekoot, W. Oostdijk

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)611-621
JournalEuropean Journal of Endocrinology
Volume173
Issue number5
DOIs
Publication statusPublished - 2015

Cite this